Atlas Trials

The Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine

Clinical trial NCT01529892 · WITHDRAWN

Trial details

NCT number
NCT01529892
Sponsor
California Pacific Medical Center Research Institute
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Methamphetamine Metabolism, CYP2D6 Genotype
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.